|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jafari SH, Saadatpour Z, Salmaninejad A,
Momeni F, Mokhtari M, Nahand JS, Rahmati M, Mirzaei H and Kianmehr
M: Breast cancer diagnosis: Imaging techniques and biochemical
markers. J Cell Physiol. 233:5200–5213. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mustacchi G and De Laurentiis M: The role
of taxanes in triple-negative breast cancer: Literature review.
Drug Des Devel Ther. 9:4303–4318. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bidkar AP, Sanpui P and Ghosh SS:
Efficient induction of apoptosis in cancer cells by
paclitaxel-loaded selenium nanoparticles. Nanomedicine (Lond).
12:2641–2651. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Karimi G, Vahabzadeh M, Lari P, Rashedinia
M and Moshiri M: ‘Silymarin’, a promising pharmacological agent for
treatment of diseases. Iran J Basic Med Sci. 14:308–317.
2011.PubMed/NCBI
|
|
6
|
Razavi-Azarkhiavi K, Iranshahy M, Sahebkar
A, Shirani K and Karimi G: The protective role of phenolic
compounds against doxorubicin-induced cardiotoxicity: A
comprehensive review. Nutr Cancer. 68:892–917. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Stage TB, Bergmann TK and Kroetz DL:
Clinical pharmacokinetics of paclitaxel monotherapy: An updated
literature review. Clin Pharmacokinet. 57:7–19. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zheng X, Wang C, Xing Y, Chen S, Meng T,
You H, Ojima I and Dong Y: SB-T-121205, a next-generation taxane,
enhances apoptosis and inhibits migration/invasion in MCF-7/PTX
cells. Int J Oncol. 50:893–902. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang Y, Yu J, Cui R, Lin J and Ding X:
Curcumin in treating breast cancer: A review. J Lab Autom.
21:723–731. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Robles-Escajeda E, Das U, Ortega NM, Parra
K, Francia G, Dimmock JR, Varela-Ramirez A and Aguilera RJ: A novel
curcumin-like dienone induces apoptosis in triple-negative breast
cancer cells. Cell Oncol (Dordr). 39:265–277. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ko EY and Moon A: Natural products for
chemoprevention of breast cancer. J Cancer Prev. 20:223–231. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Księżakowska-Łakoma K, Żyła M and
Wilczyński JR: Mitochondrial dysfunction in cancer. Prz
Menopauzalny. 13:136–144. 2014.PubMed/NCBI
|
|
13
|
Cui L, Bu W, Song J, Feng L, Xu T, Liu D,
Ding W, Wang J, Li C, Ma B, et al: Apoptosis induction by
alantolactone in breast cancer MDA-MB-231 cells through reactive
oxygen species-mediated mitochondrion-dependent pathway. Arch Pharm
Res. 41:299–313. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li J, Dou D, Li P, Luo W, Lv W, Zhang C,
Song X, Yang Y, Zhang Y, Xu Y, et al: PARP-1 serves as a novel
molecular marker for hepatocellular carcinoma in a Southern Chinese
Zhuang population. Tumour Biol. 39:10104283177069142017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lucarini L, Durante M, Lanzi C, Pini A,
Boccalini G, Calosi L, Moroni F, Masini E and Mannaioni G:
HYDAMTIQ, a selective PARP-1 inhibitor, improves bleomycin-induced
lung fibrosis by dampening the TGF-β/SMAD signalling pathway. J
Cell Mol Med. 21:324–335. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Schuhwerk H, Atteya R, Siniuk K and Wang
ZQ: PARPing for balance in the homeostasis of
poly(ADP-ribosyl)ation. Semin Cell Dev Biol. 63:81–91. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Darvishi B, Farahmand L, Eslami-S Z and
Majidzadeh-A K: NF-κB as the main node of resistance to receptor
tyrosine kinase inhibitors in triple-negative breast cancer. Tumour
Biol. 39:10104283177069192017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Baskari S, Govatati S, Madhuri V,
Nallabelli N; K PM, ; Naik S, Poornachandar Balka S, Tamanam RR and
Devi VR: Influence of autocrine growth hormone on NF-κB activation
leading to epithelial-mesenchymal transition of mammary carcinoma.
Tumour Biol. 39:10104283177191212017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Juríková M, Danihel Ľ, Polák Š and Varga
I: Ki67, PCNA, and MCM proteins: Markers of proliferation in the
diagnosis of breast cancer. Acta Histochem. 118:544–552. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang SC: PCNA: A silent housekeeper or a
potential therapeutic target? Trends Pharmacol Sci. 35:178–186.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lossi L, Cocito C, Alasia S and Merighi A:
Ex vivo imaging of active caspase 3 by a FRET-based molecular probe
demonstrates the cellular dynamics and localization of the protease
in cerebellar granule cells and its regulation by the
apoptosis-inhibiting protein survivin. Mol Neurodegener. 11:342016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gallardo M and Calaf GM: Curcumin and
epithelial-mesenchymal transition in breast cancer cells
transformed by low doses of radiation and estrogen. Int J Oncol.
48:2534–2542. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ponce-Cusi R and Calaf GM: Apoptotic
activity of 5-fluorouracil in breast cancer cells transformed by
low doses of ionizing α-particle radiation. Int J Oncol.
48:774–782. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yan G, Graham K and Lanza-Jacoby S:
Curcumin enhances the anticancer effects of trichostatin a in
breast cancer cells. Mol Carcinog. 52:404–411. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen D, Dai F, Chen Z, Wang S, Cheng X,
Sheng Q, Lin J and Chen W: Dimethoxy curcumin induces apoptosis by
suppressing survivin and inhibits invasion by enhancing E-cadherin
in colon cancer cells. Med Sci Monit. 22:3215–3222. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ganta S and Amiji M: Coadministration of
paclitaxel and curcumin in nanoemulsion formulations to overcome
multidrug resistance in tumor cells. Mol Pharm. 6:928–939. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Quispe-Soto ET and Calaf GM: Effect of
curcumin and paclitaxel on breast carcinogenesis. Int J Oncol.
49:2569–2577. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Calaf GM and Hei TK: Establishment of a
radiation- and estrogen-induced breast cancer model.
Carcinogenesis. 21:769–776. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Calaf GM, Echiburú-Chau C, Wen G, Balajee
AS and Roy D: Effect of curcumin on irradiated and
estrogen-transformed human breast cell lines. Int J Oncol.
40:436–442. 2012.PubMed/NCBI
|
|
30
|
Calaf GM, Echiburú-Chau C, Roy D, Chai Y,
Wen G and Balajee AS: Protective role of curcumin in oxidative
stress of breast cells. Oncol Rep. 26:1029–1035. 2011.PubMed/NCBI
|
